M. Alsulami

Targeting Bone Marrow to Potentiate the Anti-Tumor Effect of Tyrosine Kinase Inhibitor in Preclinical Rat Model of Human Glioblastoma.

A. Arbab, B. R. Achyut, A. Shankar, 2016, International journal of cancer research.

Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models

A. Arbab, B. R. Achyut, A. Iskander, 2017, Scientific Reports.